Literature DB >> 29894763

Adrenal serotonin derives from accumulation by the antidepressant-sensitive serotonin transporter.

Rebecca L Brindley1, Mary Beth Bauer2, L Anne Walker2, Meagan A Quinlan3, Ana M D Carneiro4, Ji-Ying Sze5, Randy D Blakely6, Kevin P M Currie7.   

Abstract

Adrenal chromaffin cells comprise the neuroendocrine arm of the sympathetic nervous system and secrete catecholamines to coordinate the appropriate stress response. Deletion of the serotonin (5-HT) transporter (SERT) gene in mice (SERT-/- mice) or pharmacological block of SERT function in rodents and humans augments this sympathoadrenal stress response (epinephrine secretion). The prevailing assumption is that loss of CNS SERT alters central drive to the peripheral sympathetic nervous system. Adrenal chromaffin cells also prominently express SERT where it might coordinate accumulation of 5-HT for reuse in the autocrine control of stress-evoked catecholamine secretion. To help test this hypothesis, we have generated a novel mouse model with selective excision of SERT in the peripheral sympathetic nervous system (SERTΔTH), generated by crossing floxed SERT mice with tyrosine hydroxylase Cre driver mice. SERT expression, assessed by western blot, was abolished in the adrenal gland but not perturbed in the CNS of SERTΔTH mice. SERT-mediated [3H] 5-HT uptake was unaltered in midbrain, hindbrain, and spinal cord synaptosomes, confirming transporter function was intact in the CNS. Endogenous midbrain and whole blood 5-HT homeostasis was unperturbed in SERTΔTH mice, contrasting with the depleted 5-HT content in SERT-/- mice. Selective SERT excision reduced adrenal gland 5-HT content by ≈ 50% in SERTΔTH mice but had no effect on adrenal catecholamine content. This novel model confirms that SERT expressed in adrenal chromaffin cells is essential for maintaining wild-type levels of 5-HT and provides a powerful tool to help dissect the role of SERT in the sympathetic stress response.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Adrenal chromaffin cell; Adrenal gland; Catecholamines; Escitalopram oxalate (CID: 146571); Serotonin; Serotonin transporter; Sympathetic nervous system

Mesh:

Substances:

Year:  2018        PMID: 29894763      PMCID: PMC6286867          DOI: 10.1016/j.phrs.2018.06.008

Source DB:  PubMed          Journal:  Pharmacol Res        ISSN: 1043-6618            Impact factor:   7.658


  55 in total

1.  Exaggerated adrenomedullary response to immobilization in mice with targeted disruption of the serotonin transporter gene.

Authors:  Olga A Tjurmina; Ines Armando; Juan M Saavedra; David S Goldstein; Dennis L Murphy
Journal:  Endocrinology       Date:  2002-12       Impact factor: 4.736

2.  Neurohormonal and inflammatory hyper-responsiveness to acute mental stress in depression.

Authors:  Ali A Weinstein; Patricia A Deuster; Jennifer L Francis; Robert W Bonsall; Russell P Tracy; Willem J Kop
Journal:  Biol Psychol       Date:  2010-01-29       Impact factor: 3.251

Review 3.  Transglutaminase 2-mediated serotonylation in pulmonary hypertension.

Authors:  K C Penumatsa; B L Fanburg
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-12-27       Impact factor: 5.464

4.  Association of depressive and anxiety symptoms with 24-hour urinary catecholamines in individuals with untreated high blood pressure.

Authors:  Nicola J Paine; Lana L Watkins; James A Blumenthal; Cynthia M Kuhn; Andrew Sherwood
Journal:  Psychosom Med       Date:  2015 Feb-Mar       Impact factor: 4.312

5.  Regulation of gene expression of catecholamine biosynthetic enzymes by stress.

Authors:  E L Sabban; B B Nankova; L I Serova; B Hiremagalur; M Rusnak; E Saez; B Spiegelman; R Kvetnanský
Journal:  Adv Pharmacol       Date:  1998

6.  Adrenal GRK2 upregulation mediates sympathetic overdrive in heart failure.

Authors:  Anastasios Lymperopoulos; Giuseppe Rengo; Hajime Funakoshi; Andrea D Eckhart; Walter J Koch
Journal:  Nat Med       Date:  2007-02-18       Impact factor: 53.440

Review 7.  Glucose counterregulatory responses to hypoglycemia.

Authors:  Jennifer E Sprague; Ana María Arbeláez
Journal:  Pediatr Endocrinol Rev       Date:  2011-09

8.  Brain organic cation transporter 2 controls response and vulnerability to stress and GSK3β signaling.

Authors:  T Couroussé; A Bacq; C Belzung; B Guiard; L Balasse; F Louis; A-M Le Guisquet; A M Gardier; A H Schinkel; B Giros; S Gautron
Journal:  Mol Psychiatry       Date:  2014-08-05       Impact factor: 15.992

9.  Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene.

Authors:  Avshalom Caspi; Karen Sugden; Terrie E Moffitt; Alan Taylor; Ian W Craig; HonaLee Harrington; Joseph McClay; Jonathan Mill; Judy Martin; Antony Braithwaite; Richie Poulton
Journal:  Science       Date:  2003-07-18       Impact factor: 47.728

10.  Body distribution of infused serotonin in rats.

Authors:  A Elizabeth Linder; Kevin M Beggs; Robert J Burnett; Stephanie W Watts
Journal:  Clin Exp Pharmacol Physiol       Date:  2009-01-18       Impact factor: 2.557

View more
  3 in total

1.  Serotonin limits generation of chromaffin cells during adrenal organ development.

Authors:  Polina Kameneva; Victoria I Melnikova; Maria Eleni Kastriti; Anastasia Kurtova; Emil Kryukov; Aliia Murtazina; Louis Faure; Irina Poverennaya; Artem V Artemov; Tatiana S Kalinina; Nikita V Kudryashov; Michael Bader; Jan Skoda; Petr Chlapek; Lucie Curylova; Lukas Sourada; Jakub Neradil; Marketa Tesarova; Massimo Pasqualetti; Patricia Gaspar; Vasily D Yakushov; Boris I Sheftel; Tomas Zikmund; Jozef Kaiser; Kaj Fried; Natalia Alenina; Elena E Voronezhskaya; Igor Adameyko
Journal:  Nat Commun       Date:  2022-05-25       Impact factor: 17.694

Review 2.  Serotonin Transporter Ala276 Mouse: Novel Model to Assess the Neurochemical and Behavioral Impact of Thr276 Phosphorylation In Vivo.

Authors:  Carina Meinke; Meagan A Quinlan; Krista C Paffenroth; Fiona E Harrison; Cristina Fenollar-Ferrer; Rania M Katamish; Isabel Stillman; Sammanda Ramamoorthy; Randy D Blakely
Journal:  Neurochem Res       Date:  2021-04-08       Impact factor: 3.996

Review 3.  S100A10 and its binding partners in depression and antidepressant actions.

Authors:  Michelle X Chen; Yong-Seok Oh; Yong Kim
Journal:  Front Mol Neurosci       Date:  2022-08-15       Impact factor: 6.261

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.